| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 3.00e-18 | 26 | 80 | 10 | GO:0005248 |
| GeneOntologyMolecularFunction | sodium channel activity | NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 8.22e-15 | 52 | 80 | 10 | GO:0005272 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A SLC29A1 | 1.61e-13 | 171 | 80 | 13 | GO:0015081 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ SLC29A1 RYR1 | 3.98e-11 | 465 | 80 | 16 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 | 8.11e-11 | 343 | 80 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ RYR1 | 3.56e-10 | 459 | 80 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ SLC29A1 RYR1 | 8.74e-10 | 664 | 80 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ SLC29A1 RYR1 | 1.75e-09 | 793 | 80 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion binding | 1.77e-09 | 14 | 80 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1A NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ RYR1 | 2.24e-09 | 525 | 80 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ RYR1 | 2.30e-09 | 526 | 80 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ SLC29A1 RYR1 | 3.08e-09 | 627 | 80 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ SLC29A1 RYR1 XPR1 | 6.38e-09 | 758 | 80 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.60e-08 | 26 | 80 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ SLC29A1 RYR1 XPR1 | 1.45e-07 | 1180 | 80 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ SLC29A1 RYR1 XPR1 | 5.66e-07 | 1289 | 80 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | calmodulin binding | 3.82e-05 | 230 | 80 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.04e-05 | 17 | 80 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.74e-05 | 334 | 80 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 9.03e-05 | 22 | 80 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 1.18e-04 | 24 | 80 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.35e-04 | 6 | 80 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.24e-04 | 182 | 80 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.65e-04 | 184 | 80 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.61e-03 | 15 | 80 | 2 | GO:0140161 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.33e-03 | 18 | 80 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.59e-03 | 19 | 80 | 2 | GO:0015355 | |
| GeneOntologyMolecularFunction | proteasome binding | 2.87e-03 | 20 | 80 | 2 | GO:0070628 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 4.18e-03 | 163 | 80 | 4 | GO:0031072 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.22e-03 | 81 | 80 | 3 | GO:0015370 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 3.45e-14 | 62 | 79 | 10 | GO:0086002 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 8.93e-13 | 36 | 79 | 8 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 1.19e-12 | 87 | 79 | 10 | GO:0086001 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 2.36e-12 | 93 | 79 | 10 | GO:0086003 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 5.50e-11 | 127 | 79 | 10 | GO:0070252 |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.05e-10 | 63 | 79 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 3.49e-10 | 153 | 79 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A11 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 4.18e-10 | 208 | 79 | 11 | GO:0035725 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.44e-10 | 112 | 79 | 9 | GO:0019226 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 5.75e-10 | 275 | 79 | 12 | GO:0006814 |
| GeneOntologyBiologicalProcess | striated muscle contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A RYR1 | 6.55e-10 | 217 | 79 | 11 | GO:0006941 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 8.23e-10 | 167 | 79 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | membrane depolarization | 8.88e-10 | 121 | 79 | 9 | GO:0051899 | |
| GeneOntologyBiologicalProcess | action potential | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 4.96e-09 | 201 | 79 | 10 | GO:0001508 |
| GeneOntologyBiologicalProcess | heart contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A MC3R SCN10A | 1.80e-08 | 298 | 79 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1A NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A SLC29A1 | 2.42e-08 | 559 | 79 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | heart process | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A MC3R SCN10A | 2.61e-08 | 309 | 79 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | muscle contraction | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A RYR1 | 3.53e-07 | 400 | 79 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A SLC6A11 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 HTT | 4.54e-07 | 942 | 79 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A SLC6A11 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ RYR1 HTT | 8.45e-07 | 1115 | 79 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 HTT | 1.00e-06 | 1000 | 79 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A SLC6A11 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 HTT XPR1 | 1.25e-06 | 1017 | 79 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 HTT | 1.40e-06 | 1157 | 79 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A SLC6A11 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A PKDREJ RYR1 HTT | 1.88e-06 | 922 | 79 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A SLC6A11 SLC10A2 NALCN SCN1A PIEZO1 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A TMEM150C PKDREJ RYR1 HTT | 3.33e-06 | 1374 | 79 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | circulatory system process | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A MC3R SCN10A OCLN SLC29A1 | 3.94e-06 | 733 | 79 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 4.73e-06 | 247 | 79 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | blood circulation | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A MC3R SCN10A OCLN | 6.24e-06 | 648 | 79 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 6.61e-06 | 32 | 79 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | muscle system process | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A RYR1 | 7.30e-06 | 547 | 79 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.01e-05 | 75 | 79 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 2.38e-05 | 15 | 79 | 3 | GO:0086069 | |
| GeneOntologyBiologicalProcess | response to pain | 4.34e-05 | 51 | 79 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | UBE4B SCN1A PIEZO1 SCN2A SCN7A SCN9A SCN10A TMEM150C TSC2 MAPK8 DNAJA1 PKDREJ SLC29A1 NLRP3 RYR1 HTT | 4.86e-05 | 1361 | 79 | 16 | GO:0009628 |
| GeneOntologyBiologicalProcess | positive regulation of glial cell apoptotic process | 8.65e-05 | 4 | 79 | 2 | GO:0034352 | |
| GeneOntologyBiologicalProcess | brain development | CACNA1A BMPR1A GPR158 SCN2A SCN5A FRS2 KDM2B WLS DNAH5 BAG6 HTT CDON | 9.89e-05 | 859 | 79 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | head development | CACNA1A BMPR1A GPR158 SCN2A SCN5A FRS2 KDM2B WLS DNAH5 BAG6 HTT CDON | 1.86e-04 | 919 | 79 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 3.00e-04 | 7 | 79 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 3.00e-04 | 7 | 79 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 3.72e-04 | 247 | 79 | 6 | GO:0009952 | |
| GeneOntologyBiologicalProcess | osmosensory signaling pathway | 4.00e-04 | 8 | 79 | 2 | GO:0007231 | |
| GeneOntologyBiologicalProcess | heart trabecula morphogenesis | 4.14e-04 | 38 | 79 | 3 | GO:0061384 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR12D2 OR12D1 OR4C11 SCN1A PIEZO1 SCN9A SCN10A OR52W1 PKDREJ NLRP3 | 4.23e-04 | 722 | 79 | 10 | GO:0051606 |
| GeneOntologyBiologicalProcess | regionalization | 4.85e-04 | 478 | 79 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 5.35e-04 | 173 | 79 | 5 | GO:0009581 | |
| GeneOntologyBiologicalProcess | forebrain development | 5.63e-04 | 489 | 79 | 8 | GO:0030900 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 5.64e-04 | 175 | 79 | 5 | GO:0009582 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A SCN1A SCN2A SCN3A SCN8A SCN9A MC3R SCN10A TSC2 ADCY3 HTT | 5.66e-04 | 891 | 79 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A BMPR1A GPR158 SCN2A SCN5A FRS2 KDM2B CERS6 WLS DNAH5 BAG6 HTT CDON | 5.84e-04 | 1197 | 79 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 5.98e-04 | 43 | 79 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 6.39e-04 | 10 | 79 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | actin filament-based process | FMNL3 SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A CTNNA3 SCN9A SCN10A | 6.86e-04 | 912 | 79 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | acrosome reaction | 7.77e-04 | 47 | 79 | 3 | GO:0007340 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 7.79e-04 | 11 | 79 | 2 | GO:0016185 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 8.36e-04 | 191 | 79 | 5 | GO:0007189 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 8.75e-04 | 111 | 79 | 4 | GO:0006942 | |
| GeneOntologyBiologicalProcess | pattern specification process | 9.05e-04 | 526 | 79 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 9.31e-04 | 50 | 79 | 3 | GO:0007628 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 9.32e-04 | 12 | 79 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 9.32e-04 | 12 | 79 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | response to osmotic stress | 9.35e-04 | 113 | 79 | 4 | GO:0006970 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.07e-03 | 202 | 79 | 5 | GO:0006937 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm morphogenesis | 1.10e-03 | 13 | 79 | 2 | GO:0048340 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 1.17e-03 | 54 | 79 | 3 | GO:0008340 | |
| GeneOntologyBiologicalProcess | lateral ventricle development | 1.28e-03 | 14 | 79 | 2 | GO:0021670 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.33e-03 | 212 | 79 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.36e-03 | 57 | 79 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 1.36e-03 | 57 | 79 | 3 | GO:0061383 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 1.40e-03 | 126 | 79 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 1.47e-03 | 15 | 79 | 2 | GO:0070142 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.47e-03 | 15 | 79 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | lipid droplet formation | 1.47e-03 | 15 | 79 | 2 | GO:0140042 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.62e-18 | 17 | 80 | 9 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.04e-15 | 29 | 80 | 9 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 1.52e-09 | 235 | 80 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 2.05e-08 | 378 | 80 | 12 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 6.81e-07 | 523 | 80 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.13e-06 | 277 | 80 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 1.16e-06 | 550 | 80 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | axon | SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A SCN10A DNM3 LRRC4B TSC2 MAPK8 DNM1 HTT | 6.47e-06 | 891 | 80 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A BMPR1A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A ZAP70 RYR1 | 8.25e-06 | 785 | 80 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A SLC6A11 GPR158 SCN1A SCN2A SCN8A SCN10A DNM3 LRRC4B DNM1 HTT | 1.33e-05 | 583 | 80 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | node of Ranvier | 5.87e-05 | 20 | 80 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A SLC6A11 GPR158 SCN1A SCN2A SCN8A SCN10A DNM3 LRRC4B DNM1 SLC29A1 HTT | 1.32e-04 | 886 | 80 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | intercalated disc | 1.34e-04 | 68 | 80 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A BMPR1A COPZ1 NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A DNM1 ZAP70 RYR1 | 1.50e-04 | 1498 | 80 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | axon initial segment | 1.84e-04 | 29 | 80 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | T-tubule | 2.40e-04 | 79 | 80 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | main axon | 3.79e-04 | 89 | 80 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.22e-04 | 591 | 80 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.67e-04 | 94 | 80 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | Z disc | 2.70e-03 | 151 | 80 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 3.80e-03 | 166 | 80 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.95e-03 | 817 | 80 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | anchoring junction | FOCAD TMEM204 SCN1A SCN2A SCN5A CAMSAP3 CTNNA3 FRS2 OCLN ZAP70 | 4.00e-03 | 976 | 80 | 10 | GO:0070161 |
| HumanPheno | Impulsivity | CACNA1A GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 CDON | 4.12e-09 | 149 | 37 | 11 | HP:0100710 |
| HumanPheno | Complex febrile seizure | 6.30e-08 | 16 | 37 | 5 | HP:0011172 | |
| HumanPheno | Focal impaired awareness seizure | 1.80e-07 | 126 | 37 | 9 | HP:0002384 | |
| HumanPheno | Focal automatism seizure | 1.12e-06 | 12 | 37 | 4 | HP:0032898 | |
| HumanPheno | Rigidity | 1.79e-06 | 214 | 37 | 10 | HP:0002063 | |
| HumanPheno | Facial tics | 3.04e-06 | 15 | 37 | 4 | HP:0011468 | |
| HumanPheno | Atypical absence status epilepticus | 5.24e-06 | 17 | 37 | 4 | HP:0011151 | |
| HumanPheno | Choking episodes | 5.24e-06 | 17 | 37 | 4 | HP:0030842 | |
| HumanPheno | Generalized tonic seizure | 5.31e-06 | 64 | 37 | 6 | HP:0010818 | |
| HumanPheno | Developmental regression | CACNA1A BMPR1A NALCN SCN1A SCN2A SCN3A SCN8A SCN9A ACTL6B DNM1 WLS FITM2 HTT | 6.45e-06 | 440 | 37 | 13 | HP:0002376 |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 6.71e-06 | 18 | 37 | 4 | HP:0032860 | |
| HumanPheno | Aggressive behavior | CACNA1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.78e-06 | 516 | 37 | 14 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | CACNA1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.78e-06 | 516 | 37 | 14 | HP:0006919 |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.05e-05 | 20 | 37 | 4 | HP:0032671 | |
| HumanPheno | Status epilepticus | 1.17e-05 | 207 | 37 | 9 | HP:0002133 | |
| HumanPheno | Atypical absence seizure | 1.69e-05 | 46 | 37 | 5 | HP:0007270 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.73e-05 | 118 | 37 | 7 | HP:0011185 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.93e-05 | 8 | 37 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.93e-05 | 8 | 37 | 3 | HP:0200048 | |
| HumanPheno | Clonic seizure | 2.10e-05 | 81 | 37 | 6 | HP:0020221 | |
| HumanPheno | Reduced impulse control | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A TSC2 ACTL6B DNM1 ADCY3 NLRP3 HTT CDON | 2.39e-05 | 1032 | 37 | 19 | HP:5200045 |
| HumanPheno | Focal hemiclonic seizure | 2.67e-05 | 25 | 37 | 4 | HP:0006813 | |
| HumanPheno | EEG with multifocal slow activity | 3.10e-05 | 52 | 37 | 5 | HP:0010844 | |
| HumanPheno | Malignant hyperthermia | 3.14e-05 | 26 | 37 | 4 | HP:0002047 | |
| HumanPheno | EEG with abnormally slow frequencies | 3.39e-05 | 88 | 37 | 6 | HP:0011203 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 3.67e-05 | 27 | 37 | 4 | HP:0031475 | |
| HumanPheno | Simple febrile seizure | 3.67e-05 | 27 | 37 | 4 | HP:0011171 | |
| HumanPheno | Prenatal movement abnormality | 4.67e-05 | 246 | 37 | 9 | HP:0001557 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 4.92e-05 | 29 | 37 | 4 | HP:0032658 | |
| HumanPheno | Dialeptic seizure | 5.47e-05 | 251 | 37 | 9 | HP:0011146 | |
| HumanPheno | Limited neck range of motion | 5.59e-05 | 11 | 37 | 3 | HP:0000466 | |
| HumanPheno | Progressive gait ataxia | 5.64e-05 | 30 | 37 | 4 | HP:0007240 | |
| HumanPheno | Progressive ataxia | 5.64e-05 | 30 | 37 | 4 | HP:0001329 | |
| HumanPheno | Paresthesia | 6.30e-05 | 144 | 37 | 7 | HP:0003401 | |
| HumanPheno | Disinhibition | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.51e-05 | 807 | 37 | 16 | HP:0000734 |
| HumanPheno | Inappropriate behavior | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.51e-05 | 807 | 37 | 16 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.51e-05 | 807 | 37 | 16 | HP:5200123 |
| HumanPheno | Social disinhibition | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 6.51e-05 | 807 | 37 | 16 | HP:5200029 |
| HumanPheno | Dyskinesia | 6.61e-05 | 198 | 37 | 8 | HP:0100660 | |
| HumanPheno | Abnormal social development | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 WLS HTT CDON | 7.07e-05 | 908 | 37 | 17 | HP:0025732 |
| HumanPheno | Epilepsia partialis continua | 7.42e-05 | 12 | 37 | 3 | HP:0012847 | |
| HumanPheno | Encephalopathy | 9.30e-05 | 335 | 37 | 10 | HP:0001298 | |
| HumanPheno | Generalized clonic seizure | 9.35e-05 | 34 | 37 | 4 | HP:0011169 | |
| HumanPheno | Calcaneovalgus deformity | 9.35e-05 | 34 | 37 | 4 | HP:0001848 | |
| HumanPheno | EEG with focal sharp slow waves | 9.60e-05 | 13 | 37 | 3 | HP:0011195 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 9.60e-05 | 13 | 37 | 3 | HP:0007058 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 9.66e-05 | 154 | 37 | 7 | HP:0010930 | |
| HumanPheno | Multifocal epileptiform discharges | 9.91e-05 | 66 | 37 | 5 | HP:0010841 | |
| HumanPheno | Abnormal stomach morphology | FOCAD CACNA1A BMPR1A NALCN KLF6 UBE4B PIEZO1 SCN3A SCN8A SCN9A ACTL6B DNM1 RYR1 CDON ADGRG6 | 1.00e-04 | 742 | 37 | 15 | HP:0002577 |
| HumanPheno | Deformed tarsal bones | 1.05e-04 | 35 | 37 | 4 | HP:0008119 | |
| HumanPheno | Limitation of neck motion | 1.18e-04 | 36 | 37 | 4 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 1.18e-04 | 36 | 37 | 4 | HP:0025669 | |
| HumanPheno | Disturbance of facial expression | 1.18e-04 | 36 | 37 | 4 | HP:0005324 | |
| HumanPheno | Poor fine motor coordination | 1.23e-04 | 69 | 37 | 5 | HP:0007010 | |
| HumanPheno | Abnormal T-wave | 1.31e-04 | 37 | 37 | 4 | HP:0005135 | |
| HumanPheno | Abnormal blood potassium concentration | 1.38e-04 | 113 | 37 | 6 | HP:0011042 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.51e-04 | 15 | 37 | 3 | HP:0007207 | |
| HumanPheno | Abnormally increased volition | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 HTT CDON | 1.63e-04 | 869 | 37 | 16 | HP:5200263 |
| HumanPheno | Recurrent maladaptive behavior | FOCAD CACNA1A BMPR1A NALCN UBE4B GLDC SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A TSC2 ACTL6B DNM1 TRRAP ADCY3 NLRP3 HTT CDON | 1.74e-04 | 1293 | 37 | 20 | HP:5200241 |
| HumanPheno | Focal non-motor seizure | 1.79e-04 | 40 | 37 | 4 | HP:0032679 | |
| HumanPheno | Short attention span | FOCAD CACNA1A BMPR1A SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 CDON | 1.81e-04 | 517 | 37 | 12 | HP:0000736 |
| HumanPheno | Epileptic encephalopathy | 1.84e-04 | 119 | 37 | 6 | HP:0200134 | |
| HumanPheno | Dysgenesis of the hippocampus | 1.85e-04 | 16 | 37 | 3 | HP:0025101 | |
| HumanPheno | Reduced attention regulation | FOCAD CACNA1A BMPR1A SCN1A SCN2A SCN3A SCN8A SCN9A TSC2 ACTL6B DNM1 CDON | 2.13e-04 | 526 | 37 | 12 | HP:5200044 |
| HumanPheno | Decreased fetal movement | 2.13e-04 | 234 | 37 | 8 | HP:0001558 | |
| HumanPheno | Focal clonic seizure | 2.17e-04 | 42 | 37 | 4 | HP:0002266 | |
| HumanPheno | Myoclonus | 2.18e-04 | 371 | 37 | 10 | HP:0001336 | |
| HumanPheno | Focal motor status epilepticus | 2.24e-04 | 17 | 37 | 3 | HP:0032663 | |
| HumanPheno | Abnormal fetal physiology | 2.65e-04 | 308 | 37 | 9 | HP:0034059 | |
| HumanPheno | Visually-induced seizure | 2.67e-04 | 18 | 37 | 3 | HP:0020216 | |
| HumanPheno | Personality disorder | 2.67e-04 | 18 | 37 | 3 | HP:0012075 | |
| HumanPheno | Abnormal eating behavior | 2.75e-04 | 128 | 37 | 6 | HP:0100738 | |
| HumanPheno | Hypsarrhythmia | 3.04e-04 | 185 | 37 | 7 | HP:0002521 | |
| HumanPheno | Alien limb phenomenon | 3.05e-04 | 4 | 37 | 2 | HP:0032506 | |
| HumanPheno | Focal manual automatism seizure | 3.05e-04 | 4 | 37 | 2 | HP:0032900 | |
| HumanPheno | Focal pedal automatism seizure | 3.05e-04 | 4 | 37 | 2 | HP:0032901 | |
| HumanPheno | Dissociated sensory loss | 3.05e-04 | 4 | 37 | 2 | HP:0010835 | |
| HumanPheno | Blurred vision | 3.09e-04 | 46 | 37 | 4 | HP:0000622 | |
| HumanPheno | Poor motor coordination | 3.29e-04 | 85 | 37 | 5 | HP:0002275 | |
| HumanPheno | Hyperactivity | CACNA1A BMPR1A GLDC SCN1A SCN2A SCN3A SCN8A TSC2 ACTL6B DNM1 HTT CDON | 3.72e-04 | 558 | 37 | 12 | HP:0000752 |
| HumanPheno | Abnormal exteroceptive sensation | 4.27e-04 | 259 | 37 | 8 | HP:0033747 | |
| HumanPheno | Talipes valgus | 4.29e-04 | 21 | 37 | 3 | HP:0004684 | |
| HumanPheno | Dysesthesia | 4.29e-04 | 21 | 37 | 3 | HP:0012534 | |
| HumanPheno | Tonic seizure | 4.46e-04 | 140 | 37 | 6 | HP:0032792 | |
| HumanPheno | Apathy | 4.52e-04 | 91 | 37 | 5 | HP:0000741 | |
| HumanPheno | Second trimester onset | 4.61e-04 | 51 | 37 | 4 | HP:0034198 | |
| HumanPheno | Autism | 4.86e-04 | 264 | 37 | 8 | HP:0000717 | |
| HumanPheno | Reflex seizure | 4.94e-04 | 22 | 37 | 3 | HP:0020207 | |
| HumanPheno | Focal sensory seizure | 4.94e-04 | 22 | 37 | 3 | HP:0011157 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.06e-04 | 5 | 37 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.06e-04 | 5 | 37 | 2 | HP:0032823 | |
| HumanPheno | Seesaw nystagmus | 5.06e-04 | 5 | 37 | 2 | HP:0012044 | |
| HumanPheno | Focal head nodding automatism seizure | 5.06e-04 | 5 | 37 | 2 | HP:0032906 | |
| HumanPheno | Spontaneous pain sensation | 5.06e-04 | 5 | 37 | 2 | HP:0010833 | |
| HumanPheno | Allodynia | 5.06e-04 | 5 | 37 | 2 | HP:0012533 | |
| HumanPheno | Atonic seizure | 5.25e-04 | 94 | 37 | 5 | HP:0010819 | |
| HumanPheno | Infection-related seizure | 5.38e-04 | 145 | 37 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 5.38e-04 | 145 | 37 | 6 | HP:0032894 | |
| MousePheno | abnormal brain wave pattern | 7.56e-07 | 64 | 70 | 6 | MP:0004994 | |
| MousePheno | abnormal neurite morphology | CACNA1A GPR158 SCN1A CAMSAP3 TSC2 ACTL6B DNM1 ECPAS ADCY3 CALN1 HTT ADGRG6 | 1.73e-06 | 442 | 70 | 12 | MP:0008415 |
| MousePheno | abnormal synaptic transmission | CACNA1A LAPTM4A USP38 NALCN GPR158 SCN1A SCN2A DHFR2 SCN8A SCN9A LRRC4B TSC2 DNM1 ECPAS FITM2 ADCY3 SLC29A1 CALN1 | 3.57e-06 | 1070 | 70 | 18 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | CACNA1A LAPTM4A USP38 NALCN GPR158 SCN1A SCN2A DHFR2 SCN8A SCN9A LRRC4B TSC2 DNM1 ECPAS FITM2 ADCY3 SLC29A1 CALN1 | 3.87e-06 | 1076 | 70 | 18 | MP:0021009 |
| MousePheno | abnormal action potential | 4.39e-06 | 133 | 70 | 7 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | CACNA1A NALCN SCN1A SCN2A SCN5A SCN8A SCN9A SCN10A LRRC4B DNM1 | 5.16e-06 | 329 | 70 | 10 | MP:0002272 |
| MousePheno | abnormal seizure response to inducing agent | 6.99e-06 | 201 | 70 | 8 | MP:0009357 | |
| MousePheno | impaired limb coordination | 1.11e-05 | 59 | 70 | 5 | MP:0001524 | |
| MousePheno | seizures | CACNA1A SLC6A11 SCN1A SCN5A SCN8A SCN9A LRRC4B DNM1 ECPAS HTT | 1.14e-05 | 360 | 70 | 10 | MP:0002064 |
| MousePheno | abnormal CNS synaptic transmission | CACNA1A LAPTM4A USP38 GPR158 SCN1A SCN2A DHFR2 SCN9A LRRC4B TSC2 DNM1 ECPAS FITM2 ADCY3 SLC29A1 CALN1 | 2.17e-05 | 985 | 70 | 16 | MP:0002206 |
| MousePheno | abnormal dendrite morphology | 2.32e-05 | 237 | 70 | 8 | MP:0008143 | |
| MousePheno | increased susceptibility to malignant hyperthermia | 2.47e-05 | 2 | 70 | 2 | MP:0020214 | |
| MousePheno | abnormal posture | 2.77e-05 | 243 | 70 | 8 | MP:0001504 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | CACNA1A GLDC SCN1A SCN4A SCN5A CAMSAP3 SCN8A SCN9A KDM2B LRRC4B TSC2 ACTL6B DNAH5 BAG6 ADCY3 HTT CDON | 2.86e-05 | 1124 | 70 | 17 | MP:0011112 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CACNA1A NALCN UBE4B SCN1A PIEZO1 SCN2A SCN4A DHFR2 SCN8A SCN9A TSC2 DNM1 WLS BAG6 ADCY3 NLRP3 RYR1 HTT | 3.72e-05 | 1269 | 70 | 18 | MP:0011111 |
| MousePheno | domed cranium | 6.55e-05 | 85 | 70 | 5 | MP:0000440 | |
| MousePheno | abnormal seizure response to pharmacological agent | 9.20e-05 | 147 | 70 | 6 | MP:0000950 | |
| MousePheno | abnormal excitatory postsynaptic current frequency | 1.10e-04 | 19 | 70 | 3 | MP:0014377 | |
| MousePheno | enlarged brain ventricles | 1.28e-04 | 156 | 70 | 6 | MP:0011380 | |
| MousePheno | abnormal breathing pattern | 1.31e-04 | 303 | 70 | 8 | MP:0001951 | |
| MousePheno | abnormal behavioral response to xenobiotic | 1.49e-04 | 309 | 70 | 8 | MP:0009745 | |
| MousePheno | akinesia | 1.50e-04 | 21 | 70 | 3 | MP:0002690 | |
| MousePheno | abnormal brain ventricle size | 1.68e-04 | 164 | 70 | 6 | MP:0013229 | |
| MousePheno | abnormal spike wave discharge | 2.26e-04 | 24 | 70 | 3 | MP:0008840 | |
| MousePheno | abnormal locomotor activation | 2.41e-04 | 112 | 70 | 5 | MP:0003313 | |
| MousePheno | increased taurine level | 2.45e-04 | 5 | 70 | 2 | MP:0030635 | |
| MousePheno | postnatal lethality | CACNA1A GLDC SCN1A SCN2A SCN5A CAMSAP3 SCN8A SCN9A LRRC4B ACTL6B DNM1 DNAH5 ADCY3 NLRP3 CDON | 2.50e-04 | 1084 | 70 | 15 | MP:0002082 |
| MousePheno | brain atrophy | 2.56e-04 | 25 | 70 | 3 | MP:0012506 | |
| MousePheno | muscle twitch | 2.92e-04 | 64 | 70 | 4 | MP:0009046 | |
| MousePheno | abnormal excitatory postsynaptic currents | 3.20e-04 | 119 | 70 | 5 | MP:0002910 | |
| MousePheno | abnormal endocardium morphology | 3.23e-04 | 27 | 70 | 3 | MP:0003974 | |
| MousePheno | apnea | 3.23e-04 | 27 | 70 | 3 | MP:0001957 | |
| MousePheno | impaired muscle relaxation | 3.60e-04 | 28 | 70 | 3 | MP:0003157 | |
| MousePheno | abnormal nervous system development | CACNA1A BMPR1A NALCN GLDC SCN8A FRS2 KDM2B TSC2 ACTL6B DNM1 WLS DNAH5 BAG6 HTT CDON ADGRG6 | 3.87e-04 | 1257 | 70 | 16 | MP:0003861 |
| MousePheno | ventricular fibrillation | 5.11e-04 | 7 | 70 | 2 | MP:0006110 | |
| MousePheno | increased glycine level | 5.11e-04 | 7 | 70 | 2 | MP:0030658 | |
| MousePheno | anosmia | 5.11e-04 | 7 | 70 | 2 | MP:0004512 | |
| MousePheno | abnormal heart ventricle morphology | CMIP SLC10A2 GLDC SCN5A CAMSAP3 SCN8A CTNNA3 TSC2 FITM2 DNAH5 RYR1 ADGRG6 | 5.19e-04 | 793 | 70 | 12 | MP:0005294 |
| MousePheno | abnormal seizure response to electrical stimulation | 5.37e-04 | 32 | 70 | 3 | MP:0001650 | |
| MousePheno | abnormal muscle electrophysiology | 5.37e-04 | 32 | 70 | 3 | MP:0004145 | |
| MousePheno | abnormal brain size | 5.50e-04 | 375 | 70 | 8 | MP:0000771 | |
| MousePheno | abnormal brain ventricle morphology | 5.56e-04 | 286 | 70 | 7 | MP:0000822 | |
| MousePheno | abnormal channel response | 5.89e-04 | 33 | 70 | 3 | MP:0003484 | |
| MousePheno | impaired coordination | 6.04e-04 | 478 | 70 | 9 | MP:0001405 | |
| MousePheno | increased amino acid level | 6.53e-04 | 79 | 70 | 4 | MP:0014527 | |
| MousePheno | decreased brain size | 6.68e-04 | 295 | 70 | 7 | MP:0000774 | |
| MousePheno | abnormal hindbrain morphology | 6.70e-04 | 485 | 70 | 9 | MP:0000841 | |
| MousePheno | abnormal cerebellum morphology | 7.00e-04 | 389 | 70 | 8 | MP:0000849 | |
| MousePheno | absence seizures | 7.02e-04 | 35 | 70 | 3 | MP:0003216 | |
| MousePheno | abnormal forebrain morphology | CMIP SCN1A CAMSAP3 FRS2 LRRC4B CERS6 OCLN WLS DNAH5 BAG6 ADCY3 CALN1 HTT CDON | 7.44e-04 | 1072 | 70 | 14 | MP:0000783 |
| MousePheno | abnormal respiration | CACNA1A NALCN SCN1A SCN2A SCN4A SCN8A SCN10A DNAH5 BAG6 RYR1 | 7.45e-04 | 598 | 70 | 10 | MP:0001943 |
| MousePheno | enlarged lateral ventricles | 8.23e-04 | 84 | 70 | 4 | MP:0008535 | |
| MousePheno | abnormal respiratory function | 8.26e-04 | 399 | 70 | 8 | MP:0002327 | |
| MousePheno | abnormal brainstem morphology | 9.46e-04 | 227 | 70 | 6 | MP:0005277 | |
| MousePheno | convulsive seizures | 1.00e-03 | 153 | 70 | 5 | MP:0000947 | |
| MousePheno | nonconvulsive seizures | 1.04e-03 | 40 | 70 | 3 | MP:0000948 | |
| MousePheno | decreased excitatory postsynaptic current frequency | 1.08e-03 | 10 | 70 | 2 | MP:0014379 | |
| MousePheno | abnormal embryonic tissue morphology | BMPR1A CMIP NALCN GLDC PIEZO1 SCN5A FRS2 KDM2B TSC2 DNM1 WLS TRRAP HTT CDON | 1.10e-03 | 1116 | 70 | 14 | MP:0002085 |
| MousePheno | abnormal metencephalon morphology | 1.15e-03 | 420 | 70 | 8 | MP:0000847 | |
| MousePheno | abnormal adaptive thermogenesis | 1.35e-03 | 96 | 70 | 4 | MP:0011019 | |
| MousePheno | abnormal cerebellum development | 1.35e-03 | 96 | 70 | 4 | MP:0000854 | |
| MousePheno | lethality throughout fetal growth and development | 1.44e-03 | 435 | 70 | 8 | MP:0006208 | |
| MousePheno | muscle weakness | 1.46e-03 | 98 | 70 | 4 | MP:0000747 | |
| MousePheno | abnormal respiratory system physiology | CACNA1A USP38 NALCN SCN1A SCN2A SCN4A SCN8A SCN10A DNAH5 BAG6 ZAP70 RYR1 | 1.52e-03 | 897 | 70 | 12 | MP:0002133 |
| MousePheno | abnormal response to stress-induced hyperthermia | 1.58e-03 | 12 | 70 | 2 | MP:0010165 | |
| MousePheno | increased embryonic epiblast cell apoptosis | 1.58e-03 | 12 | 70 | 2 | MP:0011191 | |
| MousePheno | abnormal folic acid level | 1.58e-03 | 12 | 70 | 2 | MP:0011230 | |
| MousePheno | ostium secundum atrial septal defect | 1.58e-03 | 12 | 70 | 2 | MP:0010405 | |
| Domain | Na_channel_asu | 2.70e-21 | 10 | 79 | 9 | IPR001696 | |
| Domain | Na_trans_assoc | 2.70e-21 | 10 | 79 | 9 | IPR010526 | |
| Domain | Na_trans_assoc | 2.70e-21 | 10 | 79 | 9 | PF06512 | |
| Domain | Channel_four-helix_dom | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 5.93e-16 | 57 | 79 | 11 | IPR027359 |
| Domain | - | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 5.93e-16 | 57 | 79 | 11 | 1.20.120.350 |
| Domain | Na_trans_cytopl | 4.72e-15 | 6 | 79 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 4.72e-15 | 6 | 79 | 6 | IPR024583 | |
| Domain | Ion_trans_dom | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 5.38e-14 | 114 | 79 | 12 | IPR005821 |
| Domain | Ion_trans | CACNA1A NALCN SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A RYR1 | 5.38e-14 | 114 | 79 | 12 | PF00520 |
| Domain | IQ_motif_EF-hand-BS | 1.45e-10 | 90 | 79 | 9 | IPR000048 | |
| Domain | IQ | 1.79e-09 | 81 | 79 | 8 | SM00015 | |
| Domain | IQ | 5.43e-09 | 93 | 79 | 8 | PS50096 | |
| Domain | IQ | 5.43e-07 | 71 | 79 | 6 | PF00612 | |
| Domain | ARM-type_fold | 9.23e-05 | 339 | 79 | 8 | IPR016024 | |
| Domain | EF-hand-dom_pair | 2.12e-04 | 287 | 79 | 7 | IPR011992 | |
| Domain | Dynamin_central | 2.62e-04 | 6 | 79 | 2 | IPR000375 | |
| Domain | GED | 2.62e-04 | 6 | 79 | 2 | SM00302 | |
| Domain | GED | 2.62e-04 | 6 | 79 | 2 | PS51388 | |
| Domain | Dynamin_M | 2.62e-04 | 6 | 79 | 2 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 2.62e-04 | 6 | 79 | 2 | IPR019762 | |
| Domain | GED_dom | 2.62e-04 | 6 | 79 | 2 | IPR020850 | |
| Domain | GED | 2.62e-04 | 6 | 79 | 2 | PF02212 | |
| Domain | GED | 2.62e-04 | 6 | 79 | 2 | IPR003130 | |
| Domain | - | 3.56e-04 | 222 | 79 | 6 | 1.25.10.10 | |
| Domain | G_DYNAMIN_1 | 3.66e-04 | 7 | 79 | 2 | PS00410 | |
| Domain | DYNc | 3.66e-04 | 7 | 79 | 2 | SM00053 | |
| Domain | GPS | 3.97e-04 | 34 | 79 | 3 | SM00303 | |
| Domain | GPS | 5.10e-04 | 37 | 79 | 3 | IPR000203 | |
| Domain | PTX | 7.78e-04 | 10 | 79 | 2 | SM00159 | |
| Domain | Pentaxin-related | 9.48e-04 | 11 | 79 | 2 | IPR001759 | |
| Domain | Pentaxin | 9.48e-04 | 11 | 79 | 2 | PF00354 | |
| Domain | ARM-like | 9.93e-04 | 270 | 79 | 6 | IPR011989 | |
| Domain | G_DYNAMIN_dom | 1.56e-03 | 14 | 79 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.56e-03 | 14 | 79 | 2 | PS51718 | |
| Domain | Dynamin_GTPase | 1.79e-03 | 15 | 79 | 2 | IPR001401 | |
| Domain | Dynamin_N | 1.79e-03 | 15 | 79 | 2 | PF00350 | |
| Domain | Dynamin_SF | 1.79e-03 | 15 | 79 | 2 | IPR022812 | |
| Domain | HEAT_REPEAT | 3.25e-03 | 70 | 79 | 3 | PS50077 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.86e-15 | 31 | 65 | 9 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.37e-14 | 32 | 65 | 9 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A DNM3 DNM1 | 7.11e-12 | 121 | 65 | 11 | M872 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.65e-10 | 130 | 65 | 10 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.76e-08 | 203 | 65 | 10 | M5485 | |
| Pathway | WP_RETT_SYNDROME | 8.00e-08 | 48 | 65 | 6 | M39759 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A FRS2 DNM3 DNM1 ADGRG6 | 1.76e-06 | 575 | 65 | 13 | M29853 |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 6.33e-06 | 367 | 65 | 10 | M48346 | |
| Pathway | WP_DRAVET_SYNDROME | 7.76e-06 | 28 | 65 | 4 | M45519 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 1.76e-04 | 61 | 65 | 4 | M48077 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY | 3.10e-04 | 6 | 65 | 2 | M47680 | |
| Pubmed | 5.45e-21 | 9 | 81 | 8 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.32e-16 | 6 | 81 | 6 | 23652591 | |
| Pubmed | 4.83e-16 | 13 | 81 | 7 | 15123669 | ||
| Pubmed | 1.10e-14 | 9 | 81 | 6 | 15746173 | ||
| Pubmed | 6.04e-14 | 5 | 81 | 5 | 17724025 | ||
| Pubmed | 2.73e-11 | 4 | 81 | 4 | 17537961 | ||
| Pubmed | 2.73e-11 | 4 | 81 | 4 | 35031483 | ||
| Pubmed | 2.73e-11 | 4 | 81 | 4 | 29578003 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 4.09e-11 | 139 | 81 | 9 | 16985003 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 4.73e-11 | 12 | 81 | 5 | 30175250 | |
| Pubmed | 1.36e-10 | 5 | 81 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.36e-10 | 5 | 81 | 4 | 22875929 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 19284629 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 33895391 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 23859570 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 12610651 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 19699781 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 18784617 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17544618 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 32845893 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 20038812 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 28518218 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17928448 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 14973256 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 3.65e-08 | 15 | 81 | 4 | 9726281 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 10198179 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 22260870 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 35801810 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 4.86e-08 | 4 | 81 | 3 | 8974318 | |
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 1679748 | ||
| Pubmed | 1.21e-07 | 5 | 81 | 3 | 24337656 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 16029194 | ||
| Pubmed | 2.42e-07 | 6 | 81 | 3 | 23711479 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 4.23e-07 | 7 | 81 | 3 | 25818041 | |
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 4.23e-07 | 7 | 81 | 3 | 24440715 | |
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 25101983 | ||
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 9412493 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 1.01e-06 | 9 | 81 | 3 | 17884088 | |
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 1.01e-06 | 9 | 81 | 3 | 8854872 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FOCAD UBQLNL SCN3A CAMSAP3 SCN8A FRS2 RNF213 TSC2 ECPAS DNAJA1 RYR1 | 1.12e-06 | 736 | 81 | 11 | 29676528 |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 8169823 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 4.64e-06 | 104 | 81 | 5 | 31240132 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 5.36e-06 | 2 | 81 | 2 | 24642470 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 5.36e-06 | 2 | 81 | 2 | 37901435 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18318008 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 5.36e-06 | 2 | 81 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 5.36e-06 | 2 | 81 | 2 | 10827969 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19694741 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 5.36e-06 | 2 | 81 | 2 | 11245985 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30755618 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15047701 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 5.36e-06 | 2 | 81 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 5.36e-06 | 2 | 81 | 2 | 23016767 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 5.36e-06 | 2 | 81 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 5.36e-06 | 2 | 81 | 2 | 25172946 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31439038 | ||
| Pubmed | Dynamin is primed at endocytic sites for ultrafast endocytosis. | 5.36e-06 | 2 | 81 | 2 | 35809574 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31943325 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11834499 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24963135 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 5.36e-06 | 2 | 81 | 2 | 15249644 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 27690330 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26302298 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 5.36e-06 | 2 | 81 | 2 | 27174182 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18601978 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 5.36e-06 | 2 | 81 | 2 | 24998131 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 5.36e-06 | 2 | 81 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 5.36e-06 | 2 | 81 | 2 | 19465131 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 5.36e-06 | 2 | 81 | 2 | 16847056 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24360055 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 5.36e-06 | 2 | 81 | 2 | 23735284 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 32330377 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 29649454 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24673776 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26861708 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 5.36e-06 | 2 | 81 | 2 | 16111501 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33096315 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 5.36e-06 | 2 | 81 | 2 | 30944319 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 20700106 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 31292628 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38641407 | ||
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 5.36e-06 | 2 | 81 | 2 | 16054936 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 5.36e-06 | 2 | 81 | 2 | 17805013 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33712547 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26311622 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33411788 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9398841 | ||
| Pubmed | Inherited neuronal ion channelopathies: new windows on complex neurological diseases. | 5.36e-06 | 2 | 81 | 2 | 19005038 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 21377452 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 22308498 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 1846440 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 5.36e-06 | 2 | 81 | 2 | 37665666 | |
| Interaction | SCN11A interactions | 6.20e-14 | 15 | 78 | 7 | int:SCN11A | |
| Interaction | CACNA1D interactions | 3.52e-10 | 24 | 78 | 6 | int:CACNA1D | |
| Interaction | SCN5A interactions | 5.49e-10 | 47 | 78 | 7 | int:SCN5A | |
| Interaction | SCN1A interactions | 1.22e-09 | 29 | 78 | 6 | int:SCN1A | |
| Interaction | NALCN interactions | 1.49e-09 | 14 | 78 | 5 | int:NALCN | |
| Interaction | SCN9A interactions | 1.48e-08 | 21 | 78 | 5 | int:SCN9A | |
| Interaction | SCN10A interactions | 6.71e-08 | 11 | 78 | 4 | int:SCN10A | |
| Interaction | CACNA1B interactions | 3.02e-07 | 37 | 78 | 5 | int:CACNA1B | |
| Interaction | SCN8A interactions | 9.60e-07 | 20 | 78 | 4 | int:SCN8A | |
| Interaction | HCST interactions | 1.27e-06 | 205 | 78 | 8 | int:HCST | |
| Interaction | SCN4B interactions | 3.08e-06 | 8 | 78 | 3 | int:SCN4B | |
| Interaction | NEDD4L interactions | 4.00e-06 | 320 | 78 | 9 | int:NEDD4L | |
| Interaction | NEDD4 interactions | LAPTM4A BMPR1A FBXL18 SCN1A SCN2A SCN3A SCN5A SCN8A SCN9A SCN10A OCLN | 7.60e-06 | 544 | 78 | 11 | int:NEDD4 |
| Interaction | CACNA1A interactions | 8.20e-06 | 123 | 78 | 6 | int:CACNA1A | |
| Interaction | GPR17 interactions | 1.37e-05 | 283 | 78 | 8 | int:GPR17 | |
| Interaction | RHOC interactions | LAPTM4A BMPR1A CMIP RHOBTB3 FRS2 OCLN WLS SLC29A1 HTT ADGRG6 XPR1 | 1.48e-05 | 584 | 78 | 11 | int:RHOC |
| Interaction | SLC13A3 interactions | 1.97e-05 | 14 | 78 | 3 | int:SLC13A3 | |
| Interaction | OR10H1 interactions | 3.85e-05 | 49 | 78 | 4 | int:OR10H1 | |
| Interaction | SCN4A interactions | 3.91e-05 | 98 | 78 | 5 | int:SCN4A | |
| Interaction | CMKLR1 interactions | 4.52e-05 | 101 | 78 | 5 | int:CMKLR1 | |
| Interaction | GYPA interactions | 5.83e-05 | 174 | 78 | 6 | int:GYPA | |
| Interaction | HTR3A interactions | 6.23e-05 | 108 | 78 | 5 | int:HTR3A | |
| Interaction | GPR182 interactions | 6.47e-05 | 455 | 78 | 9 | int:GPR182 | |
| Interaction | TMEM9B interactions | 7.10e-05 | 111 | 78 | 5 | int:TMEM9B | |
| Interaction | RNF123 interactions | FOCAD UBQLNL SCN3A CAMSAP3 SCN8A FRS2 RNF213 TSC2 ECPAS DNAJA1 BAG6 RYR1 | 7.31e-05 | 824 | 78 | 12 | int:RNF123 |
| Interaction | SIGLECL1 interactions | 7.73e-05 | 113 | 78 | 5 | int:SIGLECL1 | |
| Interaction | CACNA1C interactions | 9.16e-05 | 61 | 78 | 4 | int:CACNA1C | |
| Interaction | SLC6A11 interactions | 1.47e-04 | 5 | 78 | 2 | int:SLC6A11 | |
| Interaction | GET3 interactions | 1.50e-04 | 130 | 78 | 5 | int:GET3 | |
| Interaction | CLRN2 interactions | 2.16e-04 | 76 | 78 | 4 | int:CLRN2 | |
| Interaction | FIS1 interactions | 2.16e-04 | 221 | 78 | 6 | int:FIS1 | |
| Interaction | ULK1 interactions | 2.65e-04 | 147 | 78 | 5 | int:ULK1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.09e-07 | 127 | 81 | 6 | chr2q24 | |
| Cytoband | 2q24.3 | 2.91e-06 | 16 | 81 | 3 | 2q24.3 | |
| Cytoband | 6p22.2-p21.31 | 3.06e-05 | 5 | 81 | 2 | 6p22.2-p21.31 | |
| Cytoband | 2q24 | 1.67e-04 | 11 | 81 | 2 | 2q24 | |
| Cytoband | 4q21.22 | 4.11e-04 | 17 | 81 | 2 | 4q21.22 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.87e-20 | 9 | 55 | 8 | 1203 | |
| GeneFamily | Olfactory receptors, family 12 | 2.72e-05 | 3 | 55 | 2 | 160 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.89e-04 | 7 | 55 | 2 | 917 | |
| GeneFamily | F-box and leucine rich repeat proteins | 1.84e-03 | 21 | 55 | 2 | 558 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.23e-03 | 181 | 55 | 4 | 694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A CMIP NALCN GPR158 SCN1A LIN54 SCN2A SCN3A SCN8A SCN9A DNM3 KDM2B LRRC4B TSC2 ACTL6B CERS6 DNM1 CALN1 CDON XPR1 | 8.59e-11 | 1106 | 80 | 20 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CACNA1A CMIP NALCN SCN1A SCN2A SCN3A SCN7A SCN8A CTNNA3 SCN9A DNM3 CERS6 WDFY4 CALN1 XPR1 | 3.04e-09 | 703 | 80 | 15 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | CACNA1A CMIP NALCN SCN2A SCN3A SCN8A SCN9A DNM3 ACTL6B ULK2 CALN1 CDON XPR1 | 5.07e-09 | 513 | 80 | 13 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CMIP NALCN SCN2A SCN3A SCN8A SCN9A DNM3 ACTL6B CERS6 MAPK8 DNM1 XPR1 | 2.03e-07 | 584 | 80 | 12 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 9.44e-06 | 450 | 80 | 9 | M39072 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 1.23e-05 | 465 | 80 | 9 | M39066 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 2.50e-05 | 389 | 80 | 8 | M39102 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SENSORY_NEURONS | 2.87e-05 | 116 | 80 | 5 | MM3649 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 3.35e-05 | 199 | 80 | 6 | M9124 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-10 | 198 | 81 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-10 | 198 | 81 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-09 | 198 | 81 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-08 | 184 | 81 | 7 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-08 | 193 | 81 | 7 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.08e-08 | 196 | 81 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.13e-08 | 200 | 81 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.54e-07 | 180 | 81 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.16e-06 | 186 | 81 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.23e-06 | 188 | 81 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 189 | 81 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 190 | 81 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.43e-06 | 193 | 81 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-06 | 194 | 81 | 6 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 197 | 81 | 6 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-06 | 198 | 81 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 1.71e-06 | 199 | 81 | 6 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 1.71e-06 | 199 | 81 | 6 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.76e-06 | 200 | 81 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 5.56e-06 | 139 | 81 | 5 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.44e-06 | 155 | 81 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 159 | 81 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 163 | 81 | 5 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 163 | 81 | 5 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 165 | 81 | 5 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-05 | 165 | 81 | 5 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 165 | 81 | 5 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 81 | 5 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 169 | 81 | 5 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 169 | 81 | 5 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 170 | 81 | 5 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-05 | 170 | 81 | 5 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-05 | 171 | 81 | 5 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 173 | 81 | 5 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 174 | 81 | 5 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 174 | 81 | 5 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 176 | 81 | 5 | 0089b50d607f4d2f18639fab0f3fc779227baa7a | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 1.84e-05 | 178 | 81 | 5 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.84e-05 | 178 | 81 | 5 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 2.05e-05 | 182 | 81 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 81 | 5 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-05 | 183 | 81 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 186 | 81 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-05 | 186 | 81 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.27e-05 | 186 | 81 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 186 | 81 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.39e-05 | 188 | 81 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.39e-05 | 188 | 81 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.45e-05 | 189 | 81 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.52e-05 | 190 | 81 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.52e-05 | 190 | 81 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 2.58e-05 | 191 | 81 | 5 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 193 | 81 | 5 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 193 | 81 | 5 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 193 | 81 | 5 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-05 | 193 | 81 | 5 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 193 | 81 | 5 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 194 | 81 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.78e-05 | 194 | 81 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-05 | 195 | 81 | 5 | bad7f2162000f29488b3c4b903dcac9a818621f7 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 196 | 81 | 5 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 196 | 81 | 5 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 2.99e-05 | 197 | 81 | 5 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-05 | 198 | 81 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.07e-05 | 198 | 81 | 5 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.14e-05 | 199 | 81 | 5 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.14e-05 | 199 | 81 | 5 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.14e-05 | 199 | 81 | 5 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.14e-05 | 199 | 81 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.22e-05 | 200 | 81 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.22e-05 | 200 | 81 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-05 | 200 | 81 | 5 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-05 | 200 | 81 | 5 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 7.76e-05 | 124 | 81 | 4 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.76e-05 | 49 | 81 | 3 | 1002c6f5cfc09eb5cf882e0cf366d9ba8e456a57 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.76e-05 | 49 | 81 | 3 | d7fc93efa70b464da39192e4bd8b1e8ad19bbec1 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 145 | 81 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.46e-04 | 146 | 81 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 149 | 81 | 4 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 149 | 81 | 4 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 149 | 81 | 4 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 151 | 81 | 4 | f41c6558a5874b6464c157027fdf202257c60e5b | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 152 | 81 | 4 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 154 | 81 | 4 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 158 | 81 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| Drug | APETx1, Anthopleura elegantissima | 2.82e-12 | 6 | 80 | 5 | ctd:C475726 | |
| Drug | Zonisamide | 1.87e-11 | 17 | 80 | 6 | DB00909 | |
| Drug | NSC7524 | CACNA1A SLC6A11 SCN2A SCN3A SCN4A SCN5A SCN7A SCN9A SCN10A ADCY3 RYR1 | 4.08e-11 | 182 | 80 | 11 | CID000005657 |
| Drug | lamotrigine | 2.89e-10 | 116 | 80 | 9 | CID000003878 | |
| Drug | AC1L1MOZ | 4.34e-10 | 27 | 80 | 6 | CID000031958 | |
| Drug | bepridil | 6.07e-10 | 126 | 80 | 9 | CID000002351 | |
| Drug | tocainide | 8.63e-10 | 30 | 80 | 6 | CID000038945 | |
| Drug | benzocaine | 3.31e-09 | 37 | 80 | 6 | CID000002337 | |
| Drug | dibucaine | 4.13e-09 | 68 | 80 | 7 | CID000003025 | |
| Drug | diprafenone | 5.28e-09 | 19 | 80 | 5 | CID000071249 | |
| Drug | flecainide | 5.61e-09 | 71 | 80 | 7 | CID000003355 | |
| Drug | gabapentin | 8.15e-09 | 169 | 80 | 9 | CID000003446 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 9.79e-09 | 8 | 80 | 4 | ctd:C489827 | |
| Drug | pilsicainide | 1.30e-08 | 46 | 80 | 6 | CID000004820 | |
| Drug | spiradoline | 1.30e-08 | 46 | 80 | 6 | CID000005620 | |
| Drug | Sodium | 1.84e-08 | 84 | 80 | 7 | ctd:D012964 | |
| Drug | AC1NT1AF | 2.37e-08 | 25 | 80 | 5 | CID005322157 | |
| Drug | Pirmenolum | 2.93e-08 | 26 | 80 | 5 | CID000004853 | |
| Drug | PbTx-1 | 3.58e-08 | 27 | 80 | 5 | CID006437089 | |
| Drug | nefopam | 3.58e-08 | 27 | 80 | 5 | CID000004450 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 4.18e-08 | 3 | 80 | 3 | ctd:C561228 | |
| Drug | paraben | 4.35e-08 | 28 | 80 | 5 | CID000007175 | |
| Drug | isradipine | 6.23e-08 | 100 | 80 | 7 | CID000003784 | |
| Drug | procaine | 6.66e-08 | 153 | 80 | 8 | CID000004914 | |
| Drug | Tetracaine | 6.85e-08 | 12 | 80 | 4 | ctd:D013748 | |
| Drug | phenytoin | 7.67e-08 | 219 | 80 | 9 | CID000001775 | |
| Drug | zonisamide | 8.17e-08 | 62 | 80 | 6 | CID000005734 | |
| Drug | NSC93767 | 8.82e-08 | 32 | 80 | 5 | CID000005658 | |
| Drug | lidocaine | 9.42e-08 | 160 | 80 | 8 | CID000003676 | |
| Drug | saxitoxin | 1.09e-07 | 65 | 80 | 6 | CID000037165 | |
| Drug | AC1L1CQC | 1.09e-07 | 65 | 80 | 6 | CID000002012 | |
| Drug | mexiletine | 1.19e-07 | 66 | 80 | 6 | CID000004178 | |
| Drug | disopyramide | 1.19e-07 | 66 | 80 | 6 | CID000003114 | |
| Drug | 5-hydroxypropafenone | 1.21e-07 | 34 | 80 | 5 | CID000107927 | |
| Drug | Lidocaine | 1.67e-07 | 4 | 80 | 3 | DB00281 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.67e-07 | 4 | 80 | 3 | ctd:C501880 | |
| Drug | riluzole | 1.80e-07 | 174 | 80 | 8 | CID000005070 | |
| Drug | aprindine | 2.16e-07 | 38 | 80 | 5 | CID000002218 | |
| Drug | carbamazepine | 2.23e-07 | 179 | 80 | 8 | CID000002554 | |
| Drug | Tetrodotoxin | 2.82e-07 | 40 | 80 | 5 | ctd:D013779 | |
| Drug | S-ropivacaine | 2.82e-07 | 40 | 80 | 5 | CID000071273 | |
| Drug | tetradotoxin | CACNA1A SLC6A11 KLF6 SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 2.98e-07 | 428 | 80 | 11 | CID000020382 |
| Drug | Scorpion Venoms | 4.16e-07 | 18 | 80 | 4 | ctd:D012604 | |
| Drug | clenbuterol | 6.87e-07 | 142 | 80 | 7 | CID000002783 | |
| Drug | indoxacarb | 7.97e-07 | 49 | 80 | 5 | CID000107720 | |
| Drug | salbutamol | 8.29e-07 | 146 | 80 | 7 | CID000002083 | |
| Drug | fenpropathrin | 8.29e-07 | 6 | 80 | 3 | ctd:C044267 | |
| Drug | GTP[S] | CACNA1A SCN3A SCN4A SCN7A SCN9A SCN10A DNM3 ACTL6B DNM1 ZP3 ADCY3 RYR1 | 1.01e-06 | 591 | 80 | 12 | CID000001764 |
| Drug | propafenone | 1.27e-06 | 98 | 80 | 6 | CID000004932 | |
| Drug | AC1NSN3X | 1.30e-06 | 54 | 80 | 5 | CID005366189 | |
| Drug | trimethoprim | 1.34e-06 | 99 | 80 | 6 | CID000005578 | |
| Drug | triamterene | 1.87e-06 | 58 | 80 | 5 | CID000005546 | |
| Drug | pyraclofos | 2.01e-06 | 106 | 80 | 6 | CID000093460 | |
| Drug | AC1OAGFB | SCN3A SCN4A SCN7A SCN9A SCN10A DNM3 ACTL6B DNM1 TRRAP ADCY3 ZAP70 | 2.83e-06 | 539 | 80 | 11 | CID006857345 |
| Drug | cyclaine | 3.46e-06 | 9 | 80 | 3 | CID000010770 | |
| Drug | Mexiletine | 3.46e-06 | 9 | 80 | 3 | ctd:D008801 | |
| Drug | resiniferatoxin | 3.57e-06 | 66 | 80 | 5 | CID000104826 | |
| Drug | isoproterenol | CACNA1A PDE4A SCN3A SCN4A SCN5A SCN7A SCN9A SCN10A ACTL6B MAPK8 ADCY3 RYR1 | 3.64e-06 | 669 | 80 | 12 | CID000003779 |
| Drug | hydrochlorothiazide | 4.13e-06 | 120 | 80 | 6 | CID000003639 | |
| Drug | GBR 12909 | 4.45e-06 | 69 | 80 | 5 | CID000003455 | |
| Drug | T2755 | 5.12e-06 | 71 | 80 | 5 | CID000005514 | |
| Drug | bupivacaine | 5.23e-06 | 125 | 80 | 6 | CID000002474 | |
| Drug | 1, 3-diallylurea | 6.29e-06 | 74 | 80 | 5 | CID000074537 | |
| Drug | imide | 6.29e-06 | 74 | 80 | 5 | CID000443040 | |
| Drug | diphenhydramine | 6.72e-06 | 75 | 80 | 5 | CID000003100 | |
| Drug | sipatrigine | 8.54e-06 | 37 | 80 | 4 | CID000060803 | |
| Drug | bupropion | 9.81e-06 | 81 | 80 | 5 | CID000000444 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.22e-05 | 2 | 80 | 2 | ctd:C502265 | |
| Drug | Hexylcaine | 1.22e-05 | 2 | 80 | 2 | DB00473 | |
| Drug | Ranolazine | 1.22e-05 | 2 | 80 | 2 | DB00243 | |
| Drug | Phenytoin | 1.22e-05 | 2 | 80 | 2 | DB00252 | |
| Drug | Flecainide | 1.22e-05 | 2 | 80 | 2 | DB01195 | |
| Drug | decamethrin | 1.28e-05 | 146 | 80 | 6 | ctd:C017180 | |
| Drug | amiodarone | 2.14e-05 | 160 | 80 | 6 | CID000002156 | |
| Drug | sodium | SLC6A11 SLC10A2 SCN2A SCN3A SCN4A SCN5A SCN7A SCN9A SCN10A ACTL6B ADCY3 SLC29A1 RYR1 | 2.36e-05 | 944 | 80 | 13 | CID000000923 |
| Drug | moricizine | 3.28e-05 | 18 | 80 | 3 | CID000034632 | |
| Drug | Dibucaine | 3.65e-05 | 3 | 80 | 2 | DB00527 | |
| Drug | fenfluramine | 3.91e-05 | 178 | 80 | 6 | CID000003337 | |
| Drug | triphosphoinositide | 4.97e-05 | 273 | 80 | 7 | CID009543520 | |
| Drug | verapamil | 5.51e-05 | 490 | 80 | 9 | CID000002520 | |
| Drug | etorphine | 5.55e-05 | 59 | 80 | 4 | CID000026721 | |
| Drug | procainamide | 5.62e-05 | 190 | 80 | 6 | CID000004913 | |
| Drug | propofol | 5.78e-05 | 191 | 80 | 6 | CID000004943 | |
| Drug | NSC759256 | 7.19e-05 | 63 | 80 | 4 | CID000125889 | |
| Drug | Fospropofol | 7.28e-05 | 4 | 80 | 2 | DB06716 | |
| Drug | Propofol | 7.28e-05 | 4 | 80 | 2 | DB00818 | |
| Drug | mibefradil | 7.65e-05 | 64 | 80 | 4 | CID000060662 | |
| Drug | Multicide | 9.09e-05 | 25 | 80 | 3 | CID000024365 | |
| Drug | synthetic pyrethrins | 1.15e-04 | 71 | 80 | 4 | CID000002982 | |
| Drug | quindine | 1.23e-04 | 219 | 80 | 6 | CID000001065 | |
| Drug | encainide | 1.28e-04 | 28 | 80 | 3 | CID000048040 | |
| Drug | DPI 201-106 | 1.28e-04 | 28 | 80 | 3 | CID000005190 | |
| Drug | isofagomine | 1.42e-04 | 75 | 80 | 4 | CID000447607 | |
| Drug | cyfluthrin | 1.43e-04 | 29 | 80 | 3 | ctd:C052570 | |
| Drug | oxcarbazepine | 1.58e-04 | 30 | 80 | 3 | CID000034312 | |
| Drug | pseudococaine | 1.73e-04 | 570 | 80 | 9 | CID000002826 | |
| Drug | forskolin from Coleus forskohlii | PDE4A KLF6 SCN3A SCN4A SCN7A SCN9A MC3R SCN10A ACTL6B MAPK8 ADCY3 RYR1 | 2.08e-04 | 1013 | 80 | 12 | CID000003413 |
| Drug | NSC15627 | 2.31e-04 | 34 | 80 | 3 | CID000002073 | |
| Drug | trans-permethrin | 2.41e-04 | 86 | 80 | 4 | CID000040159 | |
| Drug | dihydrochloride | 2.46e-04 | 159 | 80 | 5 | CID000070978 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.96e-23 | 10 | 80 | 9 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.96e-23 | 10 | 80 | 9 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.09e-21 | 12 | 80 | 9 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SCN10A | 2.37e-11 | 163 | 80 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | anxiety disorder (implicated_via_orthology) | 3.28e-09 | 22 | 80 | 5 | DOID:2030 (implicated_via_orthology) | |
| Disease | Epilepsy | 5.32e-07 | 109 | 80 | 6 | C0014544 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.59e-06 | 9 | 80 | 3 | C3502809 | |
| Disease | Epilepsy, Cryptogenic | 2.99e-06 | 82 | 80 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 2.99e-06 | 82 | 80 | 5 | C0751111 | |
| Disease | Aura | 2.99e-06 | 82 | 80 | 5 | C0236018 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 5.38e-06 | 13 | 80 | 3 | C0751122 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 7.26e-06 | 2 | 80 | 2 | C4551549 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.05e-05 | 16 | 80 | 3 | C0393706 | |
| Disease | B Virus Infection | 2.17e-05 | 3 | 80 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 2.17e-05 | 3 | 80 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 2.17e-05 | 3 | 80 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 2.17e-05 | 3 | 80 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 2.17e-05 | 3 | 80 | 2 | C0014805 | |
| Disease | Familial or sporadic hemiplegic migraine | 2.17e-05 | 3 | 80 | 2 | cv:CN295307 | |
| Disease | Familial hemiplegic migraine | 2.17e-05 | 3 | 80 | 2 | cv:C0338484 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.17e-05 | 3 | 80 | 2 | C1833661 | |
| Disease | intestinal disease (is_implicated_in) | 2.17e-05 | 3 | 80 | 2 | DOID:5295 (is_implicated_in) | |
| Disease | Brugada ECG Pattern | 4.34e-05 | 4 | 80 | 2 | C1721096 | |
| Disease | cardiovascular age measurement | 6.66e-05 | 29 | 80 | 3 | EFO_0803380 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 7.22e-05 | 5 | 80 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 7.22e-05 | 5 | 80 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 7.22e-05 | 5 | 80 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Epileptic encephalopathy | 7.39e-05 | 30 | 80 | 3 | C0543888 | |
| Disease | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 | 1.08e-04 | 6 | 80 | 2 | C3463992 | |
| Disease | Lennox-Gastaut syndrome | 1.08e-04 | 6 | 80 | 2 | C0238111 | |
| Disease | Familial benign neonatal epilepsy | 1.08e-04 | 6 | 80 | 2 | C0220669 | |
| Disease | Neurodevelopmental Disorders | 1.22e-04 | 93 | 80 | 4 | C1535926 | |
| Disease | Seizure, Febrile, Simple | 1.51e-04 | 7 | 80 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.51e-04 | 7 | 80 | 2 | C0751057 | |
| Disease | electrocardiography, PR interval | 1.51e-04 | 7 | 80 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 1.51e-04 | 7 | 80 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.51e-04 | 7 | 80 | 2 | C0020075 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.01e-04 | 8 | 80 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.01e-04 | 8 | 80 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.01e-04 | 8 | 80 | 2 | C0338479 | |
| Disease | X-linked infantile spasms | 2.01e-04 | 8 | 80 | 2 | C4552072 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.01e-04 | 8 | 80 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 2.01e-04 | 8 | 80 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 2.01e-04 | 8 | 80 | 2 | C0393703 | |
| Disease | QRS complex, QRS duration | 2.51e-04 | 45 | 80 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Febrile Convulsions | 2.58e-04 | 9 | 80 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.58e-04 | 9 | 80 | 2 | C0014550 | |
| Disease | supraventricular ectopy | 2.58e-04 | 9 | 80 | 2 | EFO_0009277 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.22e-04 | 10 | 80 | 2 | C0917800 | |
| Disease | IGF-1 measurement | 3.64e-04 | 488 | 80 | 7 | EFO_0004627 | |
| Disease | quality of life during menstruation measurement, acne | 3.93e-04 | 11 | 80 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Myoclonic Astatic Epilepsy | 3.93e-04 | 11 | 80 | 2 | C0393702 | |
| Disease | Huntington Disease, Late Onset | 4.71e-04 | 12 | 80 | 2 | C0393574 | |
| Disease | collagen disease (implicated_via_orthology) | 4.71e-04 | 12 | 80 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 4.71e-04 | 12 | 80 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 4.71e-04 | 12 | 80 | 2 | C0751208 | |
| Disease | Congenital myopathy (disorder) | 4.71e-04 | 12 | 80 | 2 | C0270960 | |
| Disease | Brugada Syndrome 1 | 5.55e-04 | 13 | 80 | 2 | C4551804 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 5.55e-04 | 13 | 80 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | T wave morphology measurement | 6.47e-04 | 14 | 80 | 2 | EFO_0008398 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 7.15e-04 | 148 | 80 | 4 | C0279702 | |
| Disease | Autistic Disorder | 7.30e-04 | 261 | 80 | 5 | C0004352 | |
| Disease | MMR-related febrile seizures | 7.45e-04 | 15 | 80 | 2 | EFO_0006519 | |
| Disease | P wave duration | 7.45e-04 | 15 | 80 | 2 | EFO_0005094 | |
| Disease | Neuralgia, Supraorbital | 8.50e-04 | 16 | 80 | 2 | C0038870 | |
| Disease | Tremor, Rubral | 8.50e-04 | 16 | 80 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.50e-04 | 16 | 80 | 2 | C0750937 | |
| Disease | Neuralgia | 8.50e-04 | 16 | 80 | 2 | C0027796 | |
| Disease | Ataxia, Motor | 8.50e-04 | 16 | 80 | 2 | C0278161 | |
| Disease | Romano-Ward Syndrome | 8.50e-04 | 16 | 80 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 8.50e-04 | 16 | 80 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 8.50e-04 | 16 | 80 | 2 | C0234249 | |
| Disease | Ataxia, Sensory | 8.50e-04 | 16 | 80 | 2 | C0240991 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 8.50e-04 | 16 | 80 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 8.50e-04 | 16 | 80 | 2 | C0423711 | |
| Disease | Abnormal coordination | 8.50e-04 | 16 | 80 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 8.50e-04 | 16 | 80 | 2 | C0427190 | |
| Disease | Paroxysmal Nerve Pain | 8.50e-04 | 16 | 80 | 2 | C0751373 | |
| Disease | Nerve Pain | 8.50e-04 | 16 | 80 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 8.50e-04 | 16 | 80 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 8.50e-04 | 16 | 80 | 2 | C0042656 | |
| Disease | Huntington Disease | 9.61e-04 | 17 | 80 | 2 | C0020179 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.08e-03 | 18 | 80 | 2 | HP_0002373 | |
| Disease | age at menarche | 1.16e-03 | 594 | 80 | 7 | EFO_0004703 | |
| Disease | Brugada syndrome | 1.20e-03 | 19 | 80 | 2 | MONDO_0015263 | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | Etat Marbre | 1.77e-03 | 23 | 80 | 2 | C0266487 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.78e-03 | 88 | 80 | 3 | EFO_0007006, GO_0036276 | |
| Disease | Brugada Syndrome (disorder) | 1.93e-03 | 24 | 80 | 2 | C1142166 | |
| Disease | West Syndrome | 1.93e-03 | 24 | 80 | 2 | C0037769 | |
| Disease | health study participation | 1.98e-03 | 195 | 80 | 4 | EFO_0010130 | |
| Disease | Ataxia | 2.09e-03 | 25 | 80 | 2 | C0004134 | |
| Disease | ergothioneine measurement | 2.26e-03 | 26 | 80 | 2 | EFO_0021163 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCSFLMLNLFVAVIM | 1796 | O00555 | |
| CAFNTLMELEVELMK | 111 | Q5JX71 | |
| LLMQMPEEEAFCVFV | 206 | Q96CN4 | |
| SLLCQNFSMVDVVML | 756 | P46379 | |
| FLMNLSMFCTVLVQL | 2906 | Q8IZF6 | |
| MQCRELFQEMAIDII | 201 | O94805 | |
| NIAMFIVVMVQICGR | 1036 | Q86SQ4 | |
| QTMVEILCLMLEYNI | 581 | Q8IY22 | |
| EDLFMCMDIQLVEAL | 256 | P31689 | |
| ICAFAMAFIISVMLI | 236 | Q9BXU9 | |
| VNLVVMLAELFMCFE | 301 | Q9P1Y5 | |
| MLAMAAFCFIAALVI | 141 | Q16625 | |
| VCLVQMFFVHALTAM | 101 | Q6IF63 | |
| MILEEFGRCLMSVIN | 721 | Q6MZP7 | |
| ISFQALCMLLDFVSM | 421 | Q5T848 | |
| IRDMLMQFVTKENCL | 156 | Q05193 | |
| MADNACVLFAVSVLM | 76 | Q15012 | |
| IREMIMQFITRENCL | 156 | Q9UQ16 | |
| METINMCLQYLDVSV | 1341 | Q5VYK3 | |
| IVMELMDANLCQVIQ | 106 | P45983 | |
| LTCIMYMIFQERDLL | 391 | P27815 | |
| NNMAMLICLIIIAVL | 131 | P22794 | |
| NELMLMAVLNCLFDS | 86 | P61923 | |
| MAVLNCLFDSLSQML | 91 | P61923 | |
| ATLVLAFLMICENMT | 146 | Q9UII6 | |
| AFLMICENMTLVEAI | 151 | Q9UII6 | |
| MLFAVMAFDLSVAIC | 111 | P58182 | |
| GCMEIFVLILMAVDR | 106 | Q6IEV9 | |
| MLLAVMAFDRFVAIC | 111 | P0DN82 | |
| MIDVMCLLQHVSAFQ | 141 | Q9UI47 | |
| MMATVCVQQLLKTLF | 1306 | P42858 | |
| FNLMLMECSICNEII | 681 | Q8NHM5 | |
| ELDMELAFLTIVCME | 136 | P13284 | |
| SFLLTFCALMIVEEM | 156 | Q8N6M3 | |
| CARAEELFNMLQEIM | 91 | Q8WU20 | |
| NIDFMVACMQFINIV | 316 | Q8IVF7 | |
| CVLGVMVLILMVFIA | 971 | Q4KMG0 | |
| GNMERIVICLMVIFL | 6 | Q9HBE4 | |
| LLISMAVCIIAMIIF | 156 | P36894 | |
| LVMANVVDMLSCLQY | 716 | O60266 | |
| FQKMCDLLFVMFAVV | 256 | Q6ZMG9 | |
| MDNIFDSMICISLVA | 116 | P41968 | |
| MFLLLNCIVAVSQNM | 1 | Q86XF0 | |
| LFQEEGMLSMVLNCI | 476 | P21817 | |
| TEAMMFIEEVCLSLL | 241 | Q5VW36 | |
| ILFRETECMAQMGLE | 716 | Q8TE73 | |
| CFVAITFMAAVMLVA | 581 | Q9NT99 | |
| AILVARCEVMAAMFN | 436 | O94955 | |
| LLALVMFSMGCNVEI | 41 | Q12908 | |
| VMMFCEVLKQQSCLL | 986 | Q96P20 | |
| EVAGQAMCLTVFLMV | 771 | P35499 | |
| FLSSFMLVMICVLIN | 2151 | Q9NTG1 | |
| MLVMICVLINLFQAV | 2156 | Q9NTG1 | |
| DAVLAFMARCLQVVM | 631 | Q96ME1 | |
| LTITMCIVLNTLFMA | 721 | Q14524 | |
| TICIVLNTLFMAMEH | 751 | Q15858 | |
| AFDISIMVLICLNMV | 1516 | Q15858 | |
| ITICIVLNTLFMAME | 766 | Q9NY46 | |
| QVFDISIMILICLNM | 1526 | Q9NY46 | |
| VMNMAAFLALVVAVL | 71 | B9EJG8 | |
| LSAIFNNVMTLCAML | 76 | Q99808 | |
| QVFDISIMILICLNM | 1541 | P35498 | |
| CFLLADMIMQSTDAI | 146 | Q8NHS1 | |
| NSLSVILMDLEYMIC | 401 | Q9UBH6 | |
| LALKENVFMMVVCIE | 2746 | Q63HN8 | |
| LIGVCQAEALMLVME | 401 | P43403 | |
| ITLCIVVNTIFMAME | 671 | Q9Y5Y9 | |
| QAFDITIMVLICLNM | 1476 | Q9Y5Y9 | |
| IVMFLVVMLCNQNYI | 911 | O95155 | |
| TICIVLNTLFMAMEH | 766 | Q99250 | |
| QVFDISIMILICLNM | 1531 | Q99250 | |
| VQKMFVQMLLNICSD | 191 | Q6ZS81 | |
| LMAVLCERMSEQIFT | 646 | Q9C0B7 | |
| MMLIFLGLDSQFVCV | 401 | P48066 | |
| QQAFDIVIMMLICLN | 1521 | Q9UQD0 | |
| QMDQLVLVFMGCLLK | 66 | Q8IYU4 | |
| TAFLVQLTELIHCMM | 371 | Q8NB14 | |
| NVMLMFTECVLDLTA | 831 | Q8IYT8 | |
| TVKLQFDMMRACNLV | 91 | Q9BSN7 | |
| ICFQAIAMMIDTDVQ | 1261 | Q01118 | |
| MLSLLACVFVEQMQT | 1231 | Q92508 | |
| MLITLACAAMTVIFF | 436 | Q5T9L3 | |
| CQEATLMVMVSKDLF | 46 | P21754 | |
| VIKCFLVAMMSLEDN | 966 | Q9Y4A5 | |
| AFLLACVATMIFMIT | 496 | O75795 | |
| LDEYIARMVQMICLL | 191 | P49815 | |
| ICTAQALLANMAAMF | 381 | P23378 | |
| MDVLPMCSIFQELQI | 1 | Q99612 | |
| LLIVMSAISLQMFCF | 516 | Q8IZF0 |